Inogen | INGN - Net Income


Inogen reported $-5.96M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 95M 3.9M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Orthofix International USD -2.22M 20.57M Dec/2025
Philips EUR 384M 233M Jun/2026
ResMed USD 383.43M 15.3M Jun/2026
Steris USD 200.1M 20.2M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
X T L Biopharmaceuticals USD -255K 298K Dec/2024
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026